JW Pharmaceutical Corporation (KRX:001065)

Market Cap	806.91B +37.4%
Revenue (ttm)	764.21B +3.8%
Net Income	57.97B -14.5%
EPS	2,508.80 -15.8%
Shares Out	n/a
PE Ratio	13.92
Forward PE	n/a
Dividend	475.00 (1.64%)
Ex-Dividend Date	Dec 27, 2024

Volume	39
Average Volume	710
Open	30,000
Previous Close	29,000
Day's Range	29,100 - 30,000
52-Week Range	26,550 - 30,200
Beta	0.99
RSI	56.11
Earnings Date	Mar 13, 2026

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 1,068
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001065

Financial Performance

In 2024, JW Pharmaceutical's revenue was 719.38 billion, a decrease of -3.89% compared to the previous year's 748.53 billion. Earnings were 60.78 billion, an increase of 64.24%.